The Department estimates that staff will devote approximately 75 hours to promulgate the rule. This includes the time required for research and analysis, drafting the rule, and complying with Wisconsin’s rule promulgation procedure.
6. List with description of all entities that may be affected by the proposed rule:
Entities that may be affected by the proposed rule include:
(a) Consumers of substance abuse prevention, intervention or treatment services, and their families.
(b) Wisconsin county and tribal agencies providing substance abuse prevention, intervention or treatment services.
(c) Treatment providers that receive funding under ch. 51, Wis. Stats., and that are governed by ch. DHS 75. (d) Other professionals involved in substance abuse prevention, intervention, treatment or coordination services.
(e) Organizations that represent consumers of substance abuse prevention, intervention or treatment services.
(f) Existing, certified providers of substance abuse prevention, intervention or treatment services under ch. DHS 75. (g) Healthcare insurers and healthcare provider organizations.
7. Summary and preliminary comparison with any existing or proposed federal regulation that is intended to address the activities to be regulated by the proposed rule:
Medical providers may seek federal certification as an Opiate Treatment Program (OTP) under 21 C.F.R. Section 291 and 42 C.F.R. Section 8.
The January 2015 Federal Guidelines for Opioid Treatment Programs, issued by the Substance Abuse and Mental Health Services Administration, states on page 43, “It is highly recommended, but not required, that OTPs provide basic primary care onsite. OTP physicians can prescribe medication as appropriate for co-occurring medical and psychiatric disorders.” 4
8. Anticipated economic impact of implementing the rule:
The proposed rule is anticipated to have no economic impact in terms of costs imposed on narcotic treatment and other substance use disorder service providers. This rule is expected to create business opportunities for additional substance use disorder and narcotic treatment providers.
Contact Person:
Mike Derr
608-267-7704
